June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Identification of CUG-containing RNA foci in cultured Fuchs endothelial corneal dystrophy cells
Author Affiliations & Notes
  • Keith H Baratz
    Ophthalmology, Mayo Clinic, Rochester, MN
  • Santanu Bhattacharya
    Ophthalmology, Mayo Clinic, Rochester, MN
  • Cindy Bahler
    Ophthalmology, Mayo Clinic, Rochester, MN
  • Ross A Aleff
    Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
  • Elisabetta Soragni
    Cell and Molecular Biology, Scripps Research Institute, La Jolla, CA
  • Jintang Du
    Cell and Molecular Biology, Scripps Research Institute, La Jolla, CA
  • Sanjay V Patel
    Ophthalmology, Mayo Clinic, Rochester, MN
  • Eric Wieben
    Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN
  • Joel M Gottesfeld
    Cell and Molecular Biology, Scripps Research Institute, La Jolla, CA
  • Michael P Fautsch
    Ophthalmology, Mayo Clinic, Rochester, MN
  • Footnotes
    Commercial Relationships Keith Baratz, None; Santanu Bhattacharya, None; Cindy Bahler, None; Ross Aleff, None; Elisabetta Soragni, None; Jintang Du, None; Sanjay Patel, None; Eric Wieben, None; Joel Gottesfeld, None; Michael Fautsch, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2576. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Keith H Baratz, Santanu Bhattacharya, Cindy Bahler, Ross A Aleff, Elisabetta Soragni, Jintang Du, Sanjay V Patel, Eric Wieben, Joel M Gottesfeld, Michael P Fautsch; Identification of CUG-containing RNA foci in cultured Fuchs endothelial corneal dystrophy cells. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2576.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Approximately 75% of Fuchs endothelial corneal dystrophy (FECD) cases in the United States are associated with a CTG trinucleotide repeat expansion in the transcription factor 4 (TCF4) gene. We have recently identified the accumulation of poly-CUG RNA transcripts and splicing cofactors (RNA foci) in corneal endothelium from FECD patients, indicating RNA toxicity due to transcribed CTG repeats as a possible cause of the disease. In this study, we evaluated human primary corneal endothelial cell (HCEC) cultures from FECD and normal patients for RNA foci in order to validate HCEC culture as a model to study RNA toxicity in FECD.

Methods: HCECs were obtained from excised Descemet membrane/endothelium during endothelial keratoplasty or from eye bank eyes and incubated overnight in 8% FBS in Opti-MEM. Cells were released from Descemet membrane by incubating in 0.02% EDTA for 1 hour with agitation. The cells were pelleted by centrifugation, washed in culture medium, pelleted again, and re-suspended in culture medium. Cells were plated into collagen type IV coated 6-well plates and incubated at 37°C in a humidified atmosphere with 5% CO2. Cell lines (n=4 normal, n=6 FECD) were probed with a CTG complementary repeat sequence (Cy3-(CAG)10) containing a fluorescent tag and visualized using a laser scanning confocal microscope. Normal and FECD RNA was isolated, made into cDNA and amplified by PCR to examine expression patterns for RNA toxicity candidate markers MBNL1, INF2, SORBS1 and ADD3. RALGAPA1 was used as a control splicing event that is independent of RNA toxicity.

Results: Nuclear RNA foci consisting of poly-CUG transcripts were present in cultured HCECs from FECD but not normal controls. Splicing patterns of MBNL1, INF2, SORBS1 and ADD3 differed between FECD and normal cells, but RALGAPA1 splicing did not differ.

Conclusions: Primary human FECD endothelial cells but not normal endothelial cells harbor RNA foci. The splicing pattern of INF2, SORBS1, ADD3 and RALGAPA1 was consistent with that seen in other repeat expansion diseases. These results validate FECD cell culture as a model to examine the role of RNA toxicity due to RNA foci development as a possible cause of FECD.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×